Colorectal carcinoma represents a major cause ofcancer deaths in the United Kingdom. Tumours detected at an early or even premalignant stage have a better prognosis. In this review we consider the argument for screening for colorectal carcinomas and discuss the means available and the implications of implementing screening programmes using some of these methods. A suggestion is made for the more rational use of limited resources to target those at greatest risk.
INTRODUCTION
It is a humbling fact that, despite advances in medical knowledge and improved anaesthetic and surgical techniques, mortality rates for patients diagnosed as having colorectal cancer have changed little in the past three decades.' This reflects the advanced stage at time of diagnosis in many cases. It is accepted that the prognosis is dependent on the age of the patient, the differentiation of the tumour and the depth of invasion at the time ofdiagnosis.2 Tumours which are restricted to the bowel wall (Dukes' A) are associated with a five year survival of 80%. These however account for less than 10% of colorectal lesions. 3' I The low occurrence ofearly tumours represents a failure to prevent colorectal carcinomas. Prevention may be primary, where aetiological factors are recognised and avoided, or secondary, where the disease is detected sooner through screenings.'
There is now evidence that animal fats have a role in the aetiology of colorectal carcinoma, while a high intake ofvegetable fibre is believed to protect against tumour development.6'7 To implement primary prevention would require re-education of the population, with major changes in dietary habits and benefits would not become apparent for many years. Before screening can be considered as a means of secondary prevention the disease must fulfil certain criteria: a) the disease must have serious consequences in the population b) an acceptable treatment must be available c) prognosis must be improved by early detection d) the incidence of the disease must be high enough to justify the cost of screening e) an acceptable screening test must be available; this should be cheap, reliable, have a high degree of sensitivity and specificity and be acceptable to the population being screened. Flexible sigmoidoscopy has many advantages over rigid sigmoidoscopy. Up to 60 cms ofrectum and colon can be examined, with 50-70% of polyps said to occur within this length of colon. 20 The examination is said to cause less discomfort than rigid sigmoidoscopy and can be performed with a minimum of bowel preparation. Interestingly two studies have shown no difference in detection of polyps when using a 35 cms scope compared with the 60 cms instrument.2728 In spite of these advantages compliance has been poor in screening programmes using the flexible scope.31 The positive predictive value is low; between 2-6% of asymptomatic patients screened were found to have adenomas > 1 cm in diameter. 29, 30 The disadvantages of flexible sigmoidoscopy are the need for training of the endoscopist, the capital outlay in providing the service and the time required. It must also be noted when using both flexible and rigid sigmoidoscopy that in recent years several reports have documented an increased incidence of right sided colonic tumours. This so called "shift to the right" will reduce the number of tumours within reach of the sigmoidoscope and may reduce the efficacy of this as a method of screening. 32' 33 COLONOSCOPY Colonoscopy provides the best opportunity for evaluating the colonic mucosa, with sensitivities and specificities of over 95% being achieved. It may also be a therapeutic procedure enabling pedunculated polyps to be removed. Its use as a population screening test is prohibited by time, expense and expertise required to perform the examination, with even an experienced endoscopist failing to reach the caecum in as many as 20% of examinations. Being more invasive it is associated with a higher complication rate with the risk of perforation reported as 1 in 500-1 in l0,000.24' 34~36 Perforation is associated with a mortality of 5 10%o.36 It cannot be recommended for screening on a population basis C The Ulster Medical Society, 1997.
but should be the method of choice in the high risk groups.
BARIUM ENEMA Barium enema has the advantage of permitting visualisation of the colon and rectum at a lower cost and with lower morbidity and mortality than colonoscopy. Criticisms of this as a population screening method include the cost, the lack of any therapeutic potential and the lower sensitivities and specificities when compared to colonoscopy. Double contrast barium enema can detect up to 90% of cancers or polyps over 1 cm in diameter. 35 Single contrast enema should be condemned as a screening test achieving sensitivities of only 0.41 for polyps and 0.7 for cancers.37 It must also be considered in the cost of the examination that should it prove positive then endoscopy may be required if polypectomy is considered. Barium enema alone is also an inadequate examination of the colorectum and should be combined with at least rigid sigmoidoscopy to improve visualisation of the rectosigmoid junction.
FAECAL OCCULT BLOOD TESTING
FOBT is often used as a preliminary diagnostic test in those presenting with non-specific abdominal symptoms. It is also used in elderly patients in whom it is considered advisable to avoid more invasive tests if possible. The basis of the test is not the detection of blood in the stool but rather the detection of an elevated faecal blood level. It has been calculated that the median daily blood loss into the gut for normal subjects is 0.6-1.2 ml/day which is equivalent to a faecal haemoglobin concentration of <2 mg/g of faeces20 38, 39 Bleeding from colorectal cancers has been shown to range from 0 to 75 ml/day with a median loss of 1.2 ml/day being recorded. 38 There are also a number of families who while failing to fulfil the strict criteria for an HNPCC kindred undoubtedly have an increased risk (see Tables II and III 
